Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Anesthesia for electroconvulsive therapy

Zhengnian Ding¹, Paul F White

¹Department of Anesthesiology and Pain Management, First Affiliated Hospital of Nanjing Medical University, China.

Anesthesia and Analgesia

|April 26, 2002

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

HSPA12A impairs lipophagy to exaggerate septic cardiomyopathy by promoting MTOR's competition against LC3-II in binding with PNPLA2.

Autophagy·2025

Same author

Integrative Mendelian randomization analysis to identify causal plasma proteins and therapeutic targets for delirium.

Progress in neuro-psychopharmacology & biological psychiatry·2025

Same author

Challenges in achieving more sustainable anaesthesia practices: a narrative review of waste reduction.

BJA open·2025

Same author

KMV-mediated cardiomyocyte-to-endothelial cell signaling drives capillary rarefaction to promote heart failure following pressure overload.

Theranostics·2025

Same author

Integration of single-cell and bulk RNA sequencing data using machine learning identifies oxidative stress-related genes LUM and PCOLCE2 as potential biomarkers for heart failure.

International journal of biological macromolecules·2025

Same author

Downregulation of HSPA12A protects heart against sepsis through suppressing mTOR-mediated inflammatory response in cardiomyocytes.

International immunopharmacology·2024